Guohong Li

449 citations
23 papers · 348 indexed · h-index 12
Topics
Lung Cancer Diagnosis and Treatment (3 papers)Medical Imaging Techniques and Applications (2 papers)Hepatocellular Carcinoma Treatment and Prognosis (2 papers)
Partner nations
ChinaUnited StatesSweden

In The Last Decade

Guohong Li

22 papers receiving 341 citations

Peers

Guohong Li
Comparison fields: 5 of 75
  • Oncology 81
  • Immunology 72
  • Molecular Biology 61
  • Epidemiology 52
  • Pulmonary and Respiratory Medicine 49
Replace H. Hassan with:
H. Hassan Egypt
Jietao Lin China
Jiaxiang Ding China
Hitoshi Teraoka Japan
Haiying Wang China
Wei Xue China
Toshiya Okumura Japan
Xue‐cheng Bi China
Yuanmeng Jin China
Guohong Li relative to H. Hassan Egypt H. Hassan's profile →
Citations per field
00.5×1.5×1.8×
H. Hassan · 1×
Citations per year

Countries citing papers authored by Guohong Li

Since Specialization
Citations

This map shows the geographic impact of Guohong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guohong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guohong Li more than expected).

Fields of papers citing papers by Guohong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guohong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guohong Li. The network helps show where Guohong Li may publish in the future.

Co-authorship network of co-authors of Guohong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Guohong Li. A scholar is included among the top collaborators of Guohong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guohong Li. Guohong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 12
4 8
5 1
6 4
7 11
8 15
9 10
10 6
11 37
12 6
13 26
14 16
15 2
16 5
17 16
18 89
19
A New Epidithiodioxopiperazine Metabolite Isolated from Gliocladium roseum YMF1.00133
13
20 3

About Guohong Li

Guohong Li is a scholar working on Immunology and Allergy, Oncology and Hepatology, having authored 23 papers that have together received 348 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (3 papers), Medical Imaging Techniques and Applications (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Immunology and Allergy (37 citations), Immunology (72 citations) and Hematology (36 citations). Guohong Li has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include John M. Sanders, Klaus Ley, Ian J. Sarembock, Elena Galkina, Melissa Bevard, Rong Jin, Weidong Zhang, Zhihui Zhong, Fei Gao and Rui Zhong. Their work appears in journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026